Skip to main content

Want a detailed portfolio tracker?

SILO Pharma (SILO) P/E (2014 - 2026)

SILO Pharma (SILO) P/E from May 13, 2014 to Jul 21, 2026. The TTM SILO Pharma (SILO) P/E is -0.76. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of SILO Pharma (SILO)

YearP/EChange
2026-0.76+21.08%
2025-0.63-20.46%
2024-0.79-25.82%
2023-1.07-52.45%
2022-2.24-159.81%
20213.75-138.37%
2020-9.77+19.84%
2019-8.16-92.85%
2018-114.11-80.25%
2017-577.86-20.00%
2016-722.33-77.27%
2015-3.18K-45.00%
2014-5.78KN/A

Comparison SILO Pharma (SILO) P/E with competitors

SILO Pharma (SILO) P/E is -0.76.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.22%
NBYStablecoin Development Corp0.00-100.56%
ENLVEnlivex Ltd0.07-109.82%
FGENFibroGen Inc0.24-131.50%
CHRSCoherus Biosciences Inc0.85-211.36%
FBIOFortress Biotech Inc0.95-224.55%
ORMPOramed Pharmaceuticals Inc1.50-297.27%
AGENAgenus Inc3.01-494.99%
INVAInnoviva Inc3.15-513.95%
VXRTVaxart Inc3.55-565.88%
CRMDCorMedix Inc3.63-576.21%
CVACCureVac N.V.4.45-683.47%
GLPGGalapagos NV4.86-737.70%
SRPTSarepta Therapeutics Inc4.88-740.74%
ABEOAbeona Therapeutics Inc5.39-807.08%
ABUSArbutus Biopharma Corp5.60-834.39%
ZVRAZevra Therapeutics Inc5.89-872.66%
SPROSpero Therapeutics Inc6.23-917.44%
CGENCompugen Ltd6.31-928.66%
RIGLRigel Pharmaceuticals6.87-1001.91%
SLXNSilexion Therapeutics Corp7.30-1057.56%
OMEROmeros Corporation9.26-1315.15%
AUPHAurinia Pharmaceuticals Inc9.58-1357.97%
PLXProtalix BioTherapeutics Inc10.89-1529.38%
ACADAcadia Pharmaceuticals Inc11.73-1639.30%
TBPHTheravance Biopharma Inc12.26-1709.33%
ADMAAdma Biologics Inc12.42-1729.81%
HRMYHarmony Biosciences Holdings Inc13.82-1913.82%
SABSSAB Biotherapeutics Inc14.14-1955.29%
NAGENiagen Bioscience Inc14.82-2044.79%
INCYIncyte Corp15.82-2176.62%
REGNRegeneron Pharmaceuticals Inc15.86-2181.09%
PBYIPuma Biotechnology Inc17.32-2372.58%
CPRXCatalyst Pharmaceuticals Inc17.44-2388.81%
EXELExelixis Inc17.54-2401.76%
TGTXTG Therapeutics Inc18.97-2589.18%
MDXGMimedx Group Inc20.55-2797.40%
XOMAXOMA Royalty Corp22.87-3102.25%
ARGXArgen X SE24.30-3289.05%
CTMXCytomX Therapeutics Inc24.82-3357.71%
XOMAOXOMA Royalty Corp25.34-3426.44%
HALOHalozyme Therapeutics Inc25.62-3463.05%
XOMAPXOMA Royalty Corp25.67-3469.14%
VRTXVertex Pharmaceuticals Inc27.99-3774.24%
RPRXRoyalty Pharma plc - Class A28.69-3865.17%
SLNOSoleno Therapeutics Inc29.02-3908.19%
ASNDAscendis Pharma A/S30.09-4048.66%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5075.86%
APLSApellis Pharmaceuticals Inc39.02-5221.44%
BMRNBiomarin Pharmaceutical Inc42.21-5640.20%
KRYSKrystal Biotech Inc45.34-6051.22%
ONCBeiGene Ltd69.54-9227.02%
PHARPharming Group N.V.75.03-9946.93%
TECHBio-Techne Corp101.96-13481.80%
VCELVericel Corp109.92-14526.92%
ALNYAlnylam Pharmaceuticals Inc117.96-15582.64%
GMABGenmab140.29-18512.83%
TLXTelix Pharmaceuticals Ltd162.15-21382.18%
CORTCorcept Therapeutics Inc212.86-28037.05%